Study of gut microbial homeostasis and targeted therapy for hepatocellular carcinoma based on eigenvalue-fitting superiority algorithm

[1] Zhu, R. X., Seto, W. K., Lai, C. L., & Yuen, M. F. (2016). Epidemiology of hepatocellular carcinoma in the asia-pacific region. Gut & Liver, 10(3). Search in Google Scholar

[2] Rob, B., Moreno, C., Van Vlierberghe, H., Bourgeois, S., Mulkay, J. P., & Vanwolleghem, T., et al. (2017). The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis c infected patients treated with direct acting antivirals with and without pegylated interferon: a belgian experience. Journal of Viral Hepatitis, 24. Search in Google Scholar

[3] Kim, D. J., Clark, P. J., Heimbach, J., Rosen, C., Sanchez, W., & Watt, K., et al. (2014). Recurrence of hepatocellular carcinoma: importance of mrecist response to chemoembolization and tumor size. American Journal of Transplantation Official Journal of the American Society of Transplantation & the American Society of Transplant Surgeons, 14(6). Search in Google Scholar

[4] Cheng, L., Gar-Yang, C., Yi-Chen, Y., Yee, C., Teh-Ia, H., & Chien-Wei, S., et al. (2017). Risk of recurrence in chronic hepatitis b patients developing hepatocellular carcinoma with antiviral secondary prevention failure. Plos One, 12(11), e0188552. Search in Google Scholar

[5] María, Reig, Zoe, Mario, Christie, & Perelló, et al. (2016). Unexpected high rate of early tumor recurrence in patients with hcv-related hcc undergoing interferon-free therapy. Journal of Hepatology, 65(4), 719-726. Search in Google Scholar

[6] Das, V., Bhattacharya, S., Chikkaputtaiah, C., Hazra, S., & Pal, M. (2019). The basics of epithelial– mesenchymal transition (emt): a study from a structure, dynamics, and functional perspective. Journal of Cellular Physiology. Search in Google Scholar

[7] Pastushenko, I., & Blanpain, C. (2018). Emt transition states during tumor progression and metastasis. Trends in Cell Biology. Search in Google Scholar

[8] Luo, W., Fedda, F., Lynch, P., & Tan, D. (2018). Cdh1 gene and hereditary diffuse gastric cancer syndrome: molecular and histological alterations and implications for diagnosis and treatment. Frontiers in Pharmacology, 9. Search in Google Scholar

[9] Bossart, E. A., Tasdemir, N., Sikora, M. J., Bahreini, A., Levine, K. M., & Chen, J., et al. (2019). Snail is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma. Breast Cancer Research & Treatment. Search in Google Scholar

[10] Schlierf, A., Altmann, E., Quancard, J., Jefferson, A. B., RenéAssenberg, & Renatus, M., et al. (2016). Targeted inhibition of the cop9 signalosome for treatment of cancer. Nature Communications, 7, 13166. Search in Google Scholar

[11] Kawade, N., Suzuki, W., Kobayashi, M., Ohno, T., Murai, A., & Horio, F. (2022). Low ascorbic acid intake induces inflammatory changes in intestine and liver of ods rats. Journal of nutritional science and vitaminology, 68(6), 481-487. Search in Google Scholar

[12] Kumagai, Y., Fujita, T., Maeda, M., Sasaki, Y., Nagaoka, M., & Huang, J., et al. (2020). A drug‐drug interaction study to evaluate the effect of tas‐303 on cyp3a activity in the small intestine and liver. The Journal of Clinical Pharmacology, 60(6). Search in Google Scholar

[13] Warner, J., Larsen, I. S., Warner, D., Hardesty, J., Song, Y., & Sun, R., et al. (2020). 323 human beta defensin 2 as a potential beneficial agent to mitigate alcohol-induced alterations in the intestine and liver: multiple underlying mechanisms. Gastroenterology, 158(6), S-1267-. Search in Google Scholar

[14] Liu, XinjianHuang, YueYuan, HaoQi, XiaoqiangManjunath, YariswamyAvella, DiegoKaifi, Jussuf T.Miao, YiLi, MinJiang, KuirongLi, Guangfu. (2019). Disruption of oncogenic liver-intestine cadherin (cdh17) drives apoptotic pancreatic cancer death. Cancer letters, 454, 204-214. Search in Google Scholar

[15] Civenni, G., Marchetti, M., Pandit, S., Monte, C. D., & Catapano, C. V. (2017). Abstract 2900: sigma-1 receptor control tumorigenic and stem cell-like phenotype in human cancers. Cancer Research, 77(13 Supplement), 2900-2900. Search in Google Scholar

[16] Chen, J., Quan, M., Chen, Z., Zeng, T., & Gao, Y. (2020). Camrelizumab in advanced or metastatic solid tumor patients with microsatellite instability–high/mismatch repair-deficient: results from an open-label exploratory study. Journal of Clinical Oncology, 38(15_suppl), e15140-e15140. Search in Google Scholar

[17] Li, H., Zhao, W., Liu, C., Jin, M., & Yoo, S. J. (2020). A novel goodness of fit test spectrum sensing using extreme eigenvalues. Chinese Journal of Electronics, 29(6), 1201-1206. Search in Google Scholar

[18] Graffelman, J. (2020). Goodness-of-fit filtering in classical metric multidimensional scaling with large datasets. Journal of Applied Statistics, 47. Search in Google Scholar